Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 183 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named S 932. Clear
Clear
Q4
AKIN GUMP STRAUSS HAUER & FELD for BIOTECHNOLOGY INNOVATION ORGANIZATION
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Health Issues
View →
Q4
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) for BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues, Defense
View →
Q4
TWENTY-FIRST CENTURY GROUP, INC. for RAFAEL HOLDINGS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $24,000.00 income
Health Issues
View →
Q4
LIFE SCIENCES PENNSYLVANIA for LIFE SCIENCES PENNSYLVANIA
4th Quarter (Oct 1 - Dec 31) 2025 · Pennsylvania · House · Senate
Medical/Disease Research/Clinical Labs, Budget/Appropriations, Copyright/Patent/Trademark, Tariff (miscellaneous tariff bills)
View →
Q4
IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q4
TIBER CREEK GROUP for ACADIA PHARMACEUTICALS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $80,000.00 income
Health Issues
View →
Q4
DLA PIPER LLP (US) for BIOTECHNOLOGY INNOVATION ORGANIZATION
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medical/Disease Research/Clinical Labs, Health Issues, Medicare/Medicaid, Pharmacy
View →
Q4
MEHLMAN CONSULTING, INC. for ULTRAGENYX PHARMACEUTICAL, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $60,000.00 income
Health Issues
View →
Q4
EVERYLIFE FOUNDATION FOR RARE DISEASES for EVERYLIFE FOUNDATION FOR RARE DISEASES
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Health Issues
View →
Q4
THE KPM GROUP DC LLC for PRAXIS PRECISION MEDICINES
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $40,000.00 income
Pharmacy
View →
Q4
THE KPM GROUP DC LLC for SOLENO THERAPEUTICS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $50,000.00 income
Health Issues
View →
Q4
CURE SMA for CURE SMA
4th Quarter (Oct 1 - Dec 31) 2025 · Illinois · House · Senate
Health Issues, Budget/Appropriations, Civil Rights/Civil Liberties, Aviation/Airlines/Airports
View →
Q4
LMH STRATEGIC SOLUTIONS for STEALTH BIOTHERAPEUTICS INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $30,000.00 income
Health Issues
View →
Q4
LMH STRATEGIC SOLUTIONS for PTC THERAPEUTICS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $50,000.00 income
Health Issues
View →
Q4
LMH STRATEGIC SOLUTIONS for IONIS PHARMACEUTICALS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $60,000.00 income
Health Issues
View →
Q4
HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate
Health Issues
View →
3A
LUNDBECK LLC for LUNDBECK LLC
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Trade (domestic/foreign), Health Issues, Medicare/Medicaid
View →
Q3
YC CONSULTING, LLC for PATIENTS RISING NOW
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $40,000.00 income
Health Issues
View →
Q3
ALSTON & BIRD LLP for TRAVERE THERAPEUTICS
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $70,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy, Medical/Disease Research/Clinical Labs
View →
Q3
EPILEPSY FOUNDATION for EPILEPSY FOUNDATION
3rd Quarter (July 1 - Sep 30) 2025 · Maryland · House · Senate
Budget/Appropriations, Health Issues, Civil Rights/Civil Liberties, Education
View →
3T
LONG STRATEGIES, INC. for YC CONSULTING, LLC ON BEHALF OF PATIENTS RISING NOW
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $10,000.00 income
Copyright/Patent/Trademark, Defense, Health Issues, Pharmacy
View →
Q3
BIOMARIN PHARMACEUTICAL INC. for BIOMARIN PHARMACEUTICAL INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid, Tariff (miscellaneous tariff bills)
View →
3A
BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Agriculture, Energy/Nuclear, Budget/Appropriations, Copyright/Patent/Trademark
View →
Q3
ALLIANCE FOR REGENERATIVE MEDICINE for ALLIANCE FOR REGENERATIVE MEDICINE
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Health Issues
View →
Q3
AVENUE SOLUTIONS for ALLIANCE FOR REGENERATIVE MEDICINE
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid
View →
Previous Page 4 of 8 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem